InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
59,437.49
(
0.35%
)
Post# of 94785
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

diggg

Send PM Follow Ignore
Followers 20
Posts 2920
Boards Moderated 0
Alias Born 10/19/2006

diggg

Re: tothe post# 6993

Wednesday, 10/21/2009 2:11:36 PM

Wednesday, October 21, 2009 2:11:36 PM

Post# of 94785
FWIW (BSPM) - China Biotech Week in Review: A Multitude of Deals and Collaborations

http://seekingalpha.com/article/167161-china-biotech-week-in-review-a-multitude-of-deals-and-collaborations?source=yahoo

Biostar Pharmaceuticals (BSPM.OB) received a China patent for Aoxing Ganbao, an external use TCM treatment for hepatitis B (see story). Biostar already has name recognition in the hepatitis B sector with its flagship product, Xin Aoxing Oleanolic Acid Capsules. Xin Aoxing Oleanolic capsules, which is the only OTC oral hepatitis treatment product approved by the SFDA, generates about 50% of Biostar’s revenues.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up